NewAmsterdam Pharma Company
NAMS
#3754
Rank
NZ$4.51 B
Marketcap
$41.13
Share price
0.36%
Change (1 day)
21.38%
Change (1 year)

P/S ratio for NewAmsterdam Pharma Company (NAMS)

P/S ratio as of March 2025 (TTM): 76.4

According to NewAmsterdam Pharma Company's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.39. At the end of 2024 the company had a P/S ratio of 43.5.

P/S ratio history for NewAmsterdam Pharma Company from 2024 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202443.5